Top Low Dose Naltrexone Practitioners to Speak at LDN Research Trust’s 4^th AIIC LDN Conference

I left the logo in case you want to use it. 😊

, the non-profit organization and charity dedicated to raising awareness of low dose naltrexone (LDN) as well as funding research and clinical trials of LDN, is hosting their fourth AIIC LDN 2017 in September 21-24, 2017, at the Sheraton Airport Hotel in Portland, Oregon.

This unique event will feature the latest information from a panel of 29 researchers and health care providers on topics ranging from practical advice about the dosing and biological action of LDN to the latest research on and experience with the use of LDN to treat a wide variety of conditions. Admission to the conference includes online access to 14.75 hours of additional recorded sessions and 20 hours of recorded case studies. As a bonus for attendance, naturopathic doctors (with upgraded tickets to claim certificates) will receive full certificated credits from either the Oregon Board of Naturopathic Medicine or American Association of Naturopathic Practitioners, and much more.

Attendees will have the opportunity to visit the conference Expo Zone, dedicated to showcasing products and services from leading pharmacy companies from USA and Canada. The Event Sponsor is

from California, USA. Their founder, Dr Ike stated: “As a compounding pharmacist, your job satisfaction is seeing the medications that you prepare make a difference, change lives, and provide hope and relief for your patients. LDN is one of those medications. When prepared and used properly, it will give one of the best results. We are passionate about

compounding and very optimistic about LDN and all the possibilities that it can offer to our patients. LDN is one of the most common compounds we make in our pharmacy, and being a sponsor for the biggest event of the year was a natural extension of our pharmacy practice.”

This is the fourth time Dr. Mark Mandel will be the MC at LDN 2017. Dr. Mandel is a pharmacist who specializes in bio-identical hormone replacement therapy, weight loss and management, pain management, and the treatment of chronic health conditions with an integration of conventional care, adjunctive therapies and natural pharmaceutical alternatives. He is the owner and president of Mark Drugs and co-host of the weekly radio health show, “The Dr and the Pharmacist.” Dr. Mandel is thrilled to support this conference again, “I believe in approaching patient care from a “ground up” point of view and that traditional medicine tends to treat chronic illness with a reactive approach vs a proactive one that addresses the real culprit, the source of the problem. I believe that LDN can enhance patient care and quality of life.”

Linda Elsegood, Trustee and founder of LDN Research Trust added: “We are thrilled to have so many expert speakers support our special event this year. We already have bookings from UK, Canada, Germany as well as the USA, and we are hopeful that some of the local medical students might make plans to attend. Reduced ticket prices for students and student group discounts are offered. For those people unable to travel and attend the three-day conference, we will be offering our global live stream service. People can watch live or at their leisure, as content will remain online for 12 months. For those booking by May 21^st, they save $30 off the already low price tickets.”

We look forward to welcoming medical professionals, patients, MDs, NDs, and DOs at our conference where attendees will hear compelling examples, experiences, and case studies from many of the world’s leading experts, practitioners, and patients who are using LDN as treatment for a range of immune-related diseases and, in many cases, achieving positive, life-changing results.

Learn more about the event: www.LDN2017.com

__________________________________________________________

About LDN Research Trust

The LDN Research Trust is a non-profit, registered charity dedicated to raising awareness of low dose naltrexone (LDN) as well as funding research and clinical trials of LDN as a treatment for multiple sclerosis, Crohn’s disease, colitis, autism, IBS, lupus, fibromyalgia, rheumatoid arthritis, chronic pain, and other autoimmune diseases. Over one million people are using LDN to achieve positive and, in many cases, life-changing results.